Gene mutations associated with anomalies of human gonad formation

Sexual Development

Volumn 7, Issue 1-3, 2013, Pages 126-146

  Bashamboo, A ^a   McElreavey, K ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Disorders of sex development; Gene mutation; Gonadal development; Gonadal dysgenesis; Infertility; Mammalian sex determination

Indexed keywords

MAMMALIA;

TRANSCRIPTION FACTOR;

CONGENITAL MALFORMATION; ENZYMOLOGY; GENETICS; GONAD; HUMAN; METABOLISM; MUTATION; ORGANOGENESIS; PATHOLOGY; REVIEW; SEX DIFFERENTIATION DISORDER; SIGNAL TRANSDUCTION;

DISORDERS OF SEX DEVELOPMENT; GONADS; HUMANS; MAP KINASE SIGNALING SYSTEM; MUTATION; ORGANOGENESIS; TRANSCRIPTION FACTORS;

EID: 84871231849     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000342188     Document Type: Article

References (192)

1. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, Charlton HM: The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 141: 1795-1803 (2000). (Pubitemid 32274410)
2. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL: A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22: 125-126 (1999). (Pubitemid 29264799)
3. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, et al: Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87: 1829-1833 (2002). (Pubitemid 34615276)
4. Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, et al: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82: 959-968 (1995).
5. Aleck KA, Argueso L, Stone J, Hackel JG, Erickson RP: True hermaphroditism with partial duplication of chromosome 22 and without SRY Am J Med Genet 85: 2-4 (1999). (Pubitemid 29256797)
6. Allali S, Muller JB, Brauner R, Lourenço D, Boudjenah R, et al: Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46,XY disorders of sex development (DSD) including hypospadias. PLoS One 6:e24117 (2011).
7. Andersson AM, Jørgensen N, Frydelund-Larsen L, Rajpert-De Meyts E, Skakkebaek NE: Impaired Leydig cell function in infertile men: A study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab 89: 3161-3167 (2004). (Pubitemid 38951879)
8. Baek WY, Kim JE: Transcriptional regulation of bone formation. Front Biosci (Schol Ed) 3: 126-135 (2011).
9. Bagheri-Fam S, Sim H, Bernard P, Jayakody I, Taketo MM, et al: Loss of Fgfr2 leads to partial XY sex reversal. Dev Biol 314: 71-83 (2008).
10. Bagheri-Fam S, Argentaro A, Svingen T, Combes AN, Sinclair AH, et al: Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. Hum Mol Genet 20: 2213-2224 (2011).
11. Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A: Isolated 46,XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab 92: 3305-3313 (2007). (Pubitemid 47236406)
12. Barbaux S, Niaudet P, Gubler MC, Grünfeld JP, Jaubert F, et al: Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17: 467-470 (1997). (Pubitemid 27518399)
13. Barsoum IB, Bingham NC, Parker KL, Jorgensen JS, Yao HH: Activation of the Hedgehog pathway in the mouse fetal ovary leads to ectopic appearance of fetal Leydig cells and female pseudohermaphroditism. Dev Biol 329: 96-103 (2009).
14. Bashamboo A, Ferraz-de-Souza B, Lourenço D, Lin L, Sebire NJ, et al: Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1. Am J Hum Genet 87: 505-512 (2010a).
15. Bashamboo A, Ledig S, Wieacker P, Achermann JC, McElreavey K: New technologies for the identification of novel genetic markers of disorders of sex development (DSD). Sex Dev 4: 213-224 (2010b).
16. Benko S, Fantes JA, Amiel J, Kleinjan DJ, Thomas S, et al: Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet 41: 359-364 (2009).
17. Benko S, Gordon CT, Mallet D, Sreenivasan R, Thauvin-Robinet C, et al: Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet 48: 825-830 (2011).
18. Bernard P, Harley VR: Acquisition of SOX transcription factor specificity through proteinprotein interaction, modulation of Wnt signalling and post-translational modification. Int J Biochem Cell Biol 42: 400-410 (2010).
19. Bérubé NG: ATRX in chromatin assembly and genome architecture during development and disease. Biochem Cell Biol 89: 435-444 (2011).
20. Biason-Lauber A: Control of sex development. Best Pract Res Clin Endocrinol Metab 24: 163-186 (2010).
21. Biason-Lauber A, Schoenle EJ: Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 67: 1563-1568 (2000).
22. Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ: A WNT4 mutation associated with Müllerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351: 792-798 (2004). (Pubitemid 39095314)
23. Biason-Lauber A, De Filippo G, Konrad D, Scarano G, Nazzaro A, Schoenle EJ: WNT4 deficiency Y a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: A case report. Hum Reprod 22: 224-229 (2007). (Pubitemid 44942690)
24. Biason-Lauber A, Konrad D, Meyer M, DeBeaufort C, Schoenle EJ: Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. Am J Hum Genet 84: 658-663 (2009).
25. Bogani D, Siggers P, Brixey R, Warr N, Beddow S, et al: Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. PLoS Biol 7:e1000196 (2009).
26. Bouchard MF, Taniguchi H, Viger RS: The effect of human GATA4 gene mutations on the activity of target gonadal promoters. J Mol Endocrinol 42: 149-160 (2009).
27. Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N: Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum Mutat 32: 1108-1113 (2011).
28. Bouma GJ, Washburn LL, Albrecht KH, Eicher EM: Correct dosage of Fog2 and Gata4 transcription factors is critical for fetal testis development in mice. Proc Natl Acad Sci USA 104: 14994-14999 (2007). (Pubitemid 47619581)
29. Bradford ST, Wilhelm D, Bandiera R, Vidal V, Schedl A, Koopman P: A cell-autonomous role for WT1 in regulating Sry in vivo. Hum Mol Genet 18: 3429-3438 (2009).
30. Brock HW, Fisher CL: Maintenance of gene expression patterns. Dev Dyn 232: 633-655 (2005). (Pubitemid 40315285)
31. Brown S, Yu C, Lanzano P, Heller D, Thomas L, et al: A de novo mutation (Gln2Stop) at the 5 end of the SRY gene leads to sex reversal with partial ovarian function. Am J Hum Genet 1998 62: 189-192 (1998). (Pubitemid 28093848)
32. Brunelli S, Faiella A, Capra V, Nigro V, Simeone A, et al: Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet 12: 94-96 (1996). (Pubitemid 26011327)
33. Büdefeld T, Tobet SA, Majdic G: Altered position of cell bodies and fibers in the ventromedial region in SF-1 knockout mice. Exp Neurol 232: 176-184 (2011).
34. Caburet S, Georges A, L'hôte D, Todeschini AL, Benayoun BA, Veitia RA: The transcription factor FOXL2: At the crossroads of ovarian physiology and pathology. Mol Cell Endocrinol 356: 55-64 (2012).
35. Cameron FJ, Hageman RM, Cooke-Yarborough C, Kwok C, Goodwin LL, et al: A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal. Hum Mol Genet 5: 1625-1630 (1996). (Pubitemid 26328880)
36. Canto P, Söderlund D, Reyes E, Méndez JP: Mutations in the desert hedgehog (DHH) gene in patients with 46,XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab 89: 4480-4483 (2004). (Pubitemid 39244458)
37. Cantor AB, Orkin SH: Coregulation of GATA factors by the Friend of GATA (FOG) family of multitype zinc finger proteins. Semin Cell Dev Biol 16: 117-128 (2005). (Pubitemid 40126882)
38. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q: R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 108: 11452-11457 (2011).
39. Chassot AA, Gregoire EP, Magliano M, Lavery R, Chaboissier MC: Genetics of ovarian differentiation: Rspo1, a major player. Sex Dev 2: 219-227 (2008).
40. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM: Male-to- female sex reversal in mice lacking fibroblast growth factor 9. Cell 104: 875-889 (2001). (Pubitemid 32289280)
41. Cordts EB, Christofolini DM, Dos Santos AA, Bianco B, Barbosa CP: Genetic aspects of premature ovarian failure: A literature review. Arch Gynecol Obstet 283: 635-643 (2011).
42. Correa RV, Domenice S, Bingham NC, Billerbeck AE, Rainey WE, et al: A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency. J Clin Endocrinol Metab 89: 1767-1772 (2004). (Pubitemid 38507932)
43. Cox JJ, Willatt L, Homfray T, Woods CG: A SOX9 duplication and familial 46,XX developmental testicular disorder. N Engl J Med 364: 91-93 (2011).
44. Crispino JD, Lodish MB, Thurberg BL, Litovsky SH, Collins T, et al: Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 15: 839-844 (2001). (Pubitemid 32295065)
45. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al: The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/ epicanthus inversus syndrome. Nat Genet 27: 159-166 (2001). (Pubitemid 32157442)
46. Das DK, Sanghavi D, Gawde H, Idicula-Thomas S, Vasudevan L: Novel homozygous mutations in Desert hedgehog gene in patients with 46,XY complete gonadal dysgenesis and prediction of its structural and functional implications by computational methods. Eur J Med Genet 54:e529-534 (2011).
47. Davis RJ: Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467 (1995).
48. De Baere E, Lemercier B, Christin-Maitre S, Durval D, Messiaen L, et al: FOXL2 mutation screening in a large panel of POF patients and XX males. J Med Genet 39:e43 (2002).
49. DeBarber AE, Eroglu Y, Merkens LS, Pappu AS, Steiner RD: Smith-Lemli-Opitz syndrome. Expert Rev Mol Med 13:e24 (2011).
50. de Lau W, Barker N, Low TY, Koo BK, Li VS, et al: Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476: 293-297 (2011).
51. Demmer L, Primack W, Loik V, Brown R, Therville N, McElreavey K: Frasier syndrome: A cause of focal segmental glomerulosclerosis in a 46,XX female. J Am Soc Nephrol 10: 2215-2218 (1999). (Pubitemid 29453500)
52. De Santa Barbara P, Bonneaud N, Boizet B, Desclozeaux M, Moniot B, et al: Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol Cell Biol 18: 6653-6665 (1998). (Pubitemid 28500554)
53. Di Pasquale E, Beck-Peccoz P, Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75: 106-111 (2004). (Pubitemid 38801906)
54. Drash A, Sherman F, Hartmann WH, Blizzard RM: A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76: 585-593 (1970).
55. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM: The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12: 1809-1817 (1998). (Pubitemid 28544177)
56. Dumic M, Lin-Su K, Leibel NI, Ciglar S, Vinci G, et al: Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual development. J Clin Endocrinol Metab 93: 182-189 (2008).
57. Enomoto R, Kinebuchi T, Sato M, Yagi H, Kurumizaka H, Yokoyama S: Stimulation of DNA strand exchange by the human TBPIP/Hop2-Mnd1 complex. J Biol Chem 281: 5575-5581 (2006). (Pubitemid 43847654)
58. Finelli P, Pincelli AI, Russo S, Bonati MT, Recalcati MP, et al: Disruption of friend of GATA 2 gene (FOG-2) by a de novo t(8; 10) chromosomal translocation is associated with heart defects and gonadal dysgenesis. Clin Genet 71: 195-204 (2007). (Pubitemid 46322657)
59. Foster JW, Dominguez-Steglich MA, Guioli S, Kwok C, Weller PA, et al: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY -related gene. Nature 372: 525-530 (1994). (Pubitemid 24368528)
60. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, et al: Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25: 279-283 (2000). (Pubitemid 30437312)
61. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, et al: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447 (2003). (Pubitemid 36917494)
62. Georg I, Bagheri-Fam S, Knower KC, Wieacker P, Scherer G, Harley VR: Mutations of the SRY-responsive enhancer of SOX9 are uncommon in XY gonadal dysgenesis. Sex Dev 4: 321-325 (2010).
63. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA: Homozygous deletions in Wilms' tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778 (1990).
64. Gurates B, Amsterdam A, Tamura M, Yang S, Zhou J, et al: WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells. Mol Cell Endocrinol 208: 61-75 (2003). (Pubitemid 37315839)
65. Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K, et al: Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress. Mol Cell 3: 521-526 (1999). (Pubitemid 29292609)
66. Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA: A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod Biomed Online 23: 97-104 (2011).
67. Hanley NA, Hagan DM, Clement-Jones M, Ball SG, Strachan T, et al: SRY, SOX9, and DAX1 expression patterns during human sex determination and gonadal development. Mech Dev 2000 91: 403-407 (2000). (Pubitemid 30125948)
68. Harada M, Murakami H, Okawa A, Okimoto N, Hiraoka S, et al: FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat Genet 41: 289-298 (2009).
69. Herpin A, Schartl M: Dmrt1 genes at the crossroads: A widespread and central class of sexual development factors in fish. FEBS J 278: 1010-1019 (2011).
70. Hinzpeter A, Aissat A, Sondo E, Costa C, Arous N, et al: Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier. PLoS Genet 6:e1001153 (2010).
71. Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T: Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 268: 7494-7502 (1993). (Pubitemid 23105648)
72. Huang B, Wang S, Ning Y, Lamb AN, Bartley J: Autosomal XX sex reversal caused by duplication of SOX9 Am J Med Genet 87: 349-353 (1999).
73. Hughes IA, Houk C, Ahmed SF, Lee PA; LWPES Consensus Group; ESPE Consensus Group: Consensus statement on management of intersex disorders. Arch Dis Child 91: 554-563 (2006). (Pubitemid 44023350)
74. Huyhn K, Renfree MB, Graves JA, Pask AJ: ATRX has a critical and conserved role in mammalian sexual differentiation. BMC Dev Biol 11: 39 (2011).
75. Ijichi H, Tanaka T, Nakamura T, Yagi H, Hakuba A, Sato M: Molecular cloning and characterization of a human homologue of TBPIP, a BRCA1 locus-related gene. Gene 248: 99-107 (2000). (Pubitemid 30259205)
76. Ingham PW, Nakano Y, Seger C: Mechanisms and functions of Hedgehog signalling across the metazoa. Nat Rev Genet 12: 393-406 (2011).
77. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, et al: The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8: 2302-2312 (1994). (Pubitemid 24314292)
78. Ion A, Telvi L, Chaussain JL, Galacteros F, Valayer J, et al: A novel mutation in the putative DNA helicase XH2 is responsible for maleto-female sex reversal associated with an atypical form of the ATR-X syndrome. Am J Hum Genet 58: 1185-1191 (1996). (Pubitemid 26153829)
79. Iyer AK, McCabe ER: Molecular mechanisms of DAX1 action. Mol Genet Metab 83: 60-73 (2004). (Pubitemid 39328074)
80. Jeays-Ward K, Hoyle C, Brennan J, Dandonneau M, Alldus G, et al: Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130: 3663-3670 (2003). (Pubitemid 37039072)
81. Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, De Rooij DG, et al: Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 18: 1610-1619 (2004). (Pubitemid 38859570)
82. Jordan BK, Mohammed M, Ching ST, Délot E, Chen XN, et al: Up-regulation of WNT4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet 68: 1102-1109 (2001). (Pubitemid 32424409)
83. Katoh-Fukui Y, Tsuchiya R, Shiroishi T, Nakahara Y, Hashimoto N, et al: Male-to-female sex reversal in M33 mutant mice. Nature 393: 688-692 (1998). (Pubitemid 28289658)
84. Katoh-Fukui Y, Owaki A, Toyama Y, Kusaka M, Shinohara Y, et al: Mouse Polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood 106: 1612-1620 (2005). (Pubitemid 41208573)
85. Kaur I, Hussain A, Naik MN, Murthy R, Honavar SG: Mutation spectrum of fork-head transcriptional factor gene (FOXL2) in Indian Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) patients. Br J Ophthalmol 95: 881-886 (2011).
86. Kawai Y, Noguchi J, Akiyama K, Takeno Y, Fujiwara Y, et al: A missense mutation of the Dhh gene is associated with male pseudohermaphroditic rats showing impaired Leydig cell development. Reproduction 141: 217-225 (2011).
87. Kelton CA, Cheng SV, Nugent NP, Schweickhardt RL, Rosenthal JL, et al: The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells. Mol Cell Endocrinol 89: 141-151 (1992).
88. Ketola I, Pentikäinen V, Vaskivuo T, Ilvesmäki V, Herva R, et al: Expression of transcription factor GATA-4 during human testicular development and disease. J Clin Endocrinol Metab 85: 3925-3931 (2000).
89. Kim KW, Zhao L, Donato J Jr, Kohno D, Xu Y, et al: Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus. Proc Natl Acad Sci USA 108: 10673-10678 (2011).
90. Kim Y, Kobayashi A, Sekido R, DiNapoli L, Brennan J, et al: Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4:e187 (2006).
91. Kim Y, Bingham N, Sekido R, Parker KL, Lovell-Badge R, Capel B: Fibroblast growth factor receptor 2 regulates proliferation and Sertoli differentiation during male sex determination. Proc Natl Acad Sci USA 104: 16558-16563 (2007). (Pubitemid 350211057)
92. King CY, Weiss MA: The SRY high-mobilitygroup box recognizes DNA by partial intercalation in the minor groove: A topological mechanism of sequence specificity. Proc Natl Acad Sci USA 90: 11990-11994 (1993). (Pubitemid 24008766)
93. Knower KC, Kelly S, Ludbrook LM, Bagheri-Fam S, Sim H, et al: Failure of SOX9 regulation in 46,XY disorders of sex development with SRY, SOX9 and SF1 mutations. PLoS One 6:e17751 (2011).
94. Ko L, Cardona GR, Henrion-Caude A, Chin WW: Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Mol Cell Biol 22: 357-369 (2002). (Pubitemid 33144281)
95. Köhler B, Lin L, Mazen I, Cetindag C, Biebermann H, et al: The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency. Eur J Endocrinol 161: 237-242 (2009).
96. Köhler B, Biebermann H, Friedsam V, Gellermann J, Maier RF, et al: Analysis of the Wilms' tumor suppressor gene (WT1) in patients 46,XY disorders of sex development. J Clin Endocrinol Metab 96:E1131-1136 (2011).
97. Kurth I, Klopocki E, Stricker S, van Oosterwijk J, Vanek S, et al: Duplications of noncoding elements 5 of SOX9 are associated with brachydactyly-anonychia. Nat Genet 41: 862-863 (2009).
98. Kusaka M, Katoh-Fukui Y, Ogawa H, Miyabayashi K, Baba T, et al: Abnormal epithelial cell polarity and ectopic epidermal growth factor receptor (EGFR) expression induced in Emx2 KO embryonic gonads. Endocrinology 151: 5893-5904 (2010).
99. Lalioti MD: Impact of follicle stimulating hormone receptor variants in fertility. Curr Opin Obstet Gynecol 23: 158-167 (2011).
100. Lappalainen T, Montgomery SB, Nica AC, Dermitzakis ET: Epistatic selection between coding and regulatory variation in human evolution and disease. Am J Hum Genet 89: 459-463 (2011).
101. Laumonnier F, Ronce N, Hamel BC, Thomas P, Lespinasse J, et al: Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 71: 1450-1455 (2002). (Pubitemid 36015898)
102. Law MJ, Lower KM, Voon HP, Hughes JR, Garrick D, et al: ATR-X syndrome protein targets tandem repeats and influences allelespecific expression in a size-dependent manner. Cell 143: 367-378 (2010).
103. Lee FY, Faivre EJ, Suzawa M, Lontok E, Ebert D, et al: Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development. Dev Cell 21: 315-327 (2011).
104. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaux M, Ingraham HA: The DEADbox protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol 25: 1879-1890 (2005). (Pubitemid 40280151)
105. Leipoldt M, Erdel M, Bien-Willner GA, Smyk M, Theurl M, et al: Two novel translocation breakpoints upstream of SOX9 define borders of the proximal and distal breakpoint cluster region in campomelic dysplasia. Clin Genet 71: 67-75 (2007). (Pubitemid 44921623)
106. Lin L, Achermann JC: Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev 2: 200-209 (2008).
107. Lourenço D, Brauner R, Lin L, De Perdigo A, Weryha G, et al: Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med 360: 1200-1210 (2009).
108. Lourenço D, Brauner R, Rybczynska M, Nihoul- Fékété C, McElreavey K, Bashamboo A: Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci USA 108: 1597-1602 (2011).
109. Luo X, Ikeda Y, Parker KL: A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77: 481-490 (1994). (Pubitemid 24153989)
110. Mandel H, Shemer R, Borochowitz ZU, Okopnik M, Knopf C, et al: SERKAL syndrome: An autosomal-recessive disorder caused by a loss-of-function mutation in WNT4 Am J Hum Genet 82: 39-47 (2008). (Pubitemid 351726078)
111. Mardo V, Squibb EE, Braverman N, Hoover-Fong JE, Migeon C, et al: Molecular cytogenetic analysis of a de novo interstitial deletion of chromosome 10q (q25.3q26.13) in a male child with ambiguous genitalia: Evidence for a new critical region for genital development. Am J Med Genet A 146A:2293-2297 (2008).
112. Matson CK, Murphy MW, Sarver AL, Griswold MD, Bardwell VJ, Zarkower D: DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature 476: 101-104 (2011).
113. McElreavey K, Fellous M: Sex determination and the Y chromosome. Am J Med Genet 89: 176-185 (1999). (Pubitemid 30180703)
114. McElreavey K, Cortes LS: X-Y translocations and sex differentiation. Semin Reprod Med 19: 133-139 (2001). (Pubitemid 32847027)
115. McElreavy K, Vilain E, Abbas N, Costa JM, Souleyreau N, et al: XY sex reversal associated with a deletion 5 to the SRY 'HMG box' in the testis-determining region. Proc Natl Acad Sci USA 89: 11016-11020 (1992).
116. McElreavey K, Vilain E, Barbaux S, Fuqua JS, Fechner PY, et al: Loss of sequences 3 to the testis-determining gene, SRY, including the Y pseudoautosomal boundary associated with partial testicular determination. Proc Natl Acad Sci USA 93: 8590-8594 (1996).
117. Merello E, Swanson E, De Marco P, Akhter M, Striano P, et al: No major role for the EMX2 gene in schizencephaly. Am J Med Genet A 146A:1142-1150 (2008). (Pubitemid 351628600)
118. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S: Defects of urogenital development in mice lacking Emx2 Development 124: 1653-1664 (1997). (Pubitemid 27248333)
119. Molkentin JD, Lin Q, Duncan SA, Olson EN: Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11: 1061-1072 (1997). (Pubitemid 27199884)
120. Morohashi K, Honda S, Inomata Y, Handa H, Omura T: A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 267: 17913-17919 (1992).
121. Morohashi K, Tsuboi-Asai H, Matsushita S, Suda M, Nakashima M, et al: Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse. Blood 93: 1586-1594 (1999). (Pubitemid 29102486)
122. Nallathambi J, Moumné L, De Baere E, Beysen D, Usha K, et al: A novel polyalanine expansion in FOXL2: The first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Hum Genet 121: 107-112 (2007). (Pubitemid 46421147)
123. Nelson LM: Clinical practice. Primary ovarian insufficiency. N Engl J Med 360: 606-614 (2009).
124. Niaudet P, Gubler MC: WT1 and glomerular diseases. Pediatr Nephrol 21: 1653-1660 (2006). (Pubitemid 44390829)
125. Nicholl RM, Grimsley L, Butler L, Palmer RW, Rees HC, et al: Trisomy 22 and intersex. Arch Dis Child Fetal Neonatal Ed 71:F57-F58 (1994). (Pubitemid 24238552)
126. Ogata T, Muroya K, Sasagawa I, Kosho T, Wakui K, et al: Genetic evidence for a novel gene(s) involved in urogenital development on 10q26. Kidney Int 58: 2281-2290 (2000).
127. Oktay K, Briggs D, Gosden RG: Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 82: 3748-3751 (1997). (Pubitemid 27509366)
128. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S: Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 275: 39523-39528 (2000). (Pubitemid 32058979)
129. Ottolenghi C, McElreavey K: Deletions of 9p and the quest for a conserved mechanism of sex determination. Mol Genet Metab 71: 397-404 (2000).
130. Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, et al: Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14: 2053-2062 (2005). (Pubitemid 41418041)
131. Pailhoux E, Vigier B, Chaffaux S, Servel N, Taourit S, et al: A 11.7-kb deletion triggers intersexuality and polledness in goats. Nat Genet 29: 453-458 (2001). (Pubitemid 34326697)
132. Park M, Shin E, Won M, Kim JH, Go H, et al: FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells. Mol Endocrinol 24: 1024-1036 (2010).
133. Park SY, Tong M, Jameson JL: Distinct roles for steroidogenic factor 1 and desert hedgehog pathways in fetal and adult Leydig cell development. Endocrinology 148: 3704-3710 (2007). (Pubitemid 47105872)
134. Parma P, Radi O, Vidal V, Chaboissier MC, Dellambra E, et al: R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 38: 1304-1309 (2006). (Pubitemid 44646293)
135. Paulini F, Melo EO: The role of oocyte-secreted factors GDF9 and BMP15 in follicular development and oogenesis. Reprod Domest Anim 46: 354-361 (2011).
136. Pearlman A, Loke J, Le Caignec C, White S, Chin L, et al: Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet 87: 898-904 (2010).
137. Petukhova GV, Romanienko PJ, Camerini-Otero RD: The Hop2 protein has a direct role in promoting interhomolog interactions during mouse meiosis. Dev Cell 5: 927-936 (2003). (Pubitemid 37527692)
138. Pfeifer D, Kist R, Dewar K, Devon K, Lander ES, et al: Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: Evidence for an extended control region. Am J Hum Genet 65: 111-124 (1999). (Pubitemid 30470455)
139. Philibert P, Zenaty D, Lin L, Soskin S, Audran F, et al: Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: A French collaborative study. Hum Reprod 22: 3255-3261 (2007). (Pubitemid 351696772)
140. Philibert P, Biason-Lauber A, Rouzier R, Pienkowski C, Paris F, et al: Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: A French collaborative study. J Clin Endocrinol Metab 93: 895-900 (2008). (Pubitemid 351398569)
141. Philibert P, Biason-Lauber A, Gueorguieva I, Stuckens C, Pienkowski C, et al: Molecular analysis of WNT4 gene in four adolescent girls with müllerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome). Fertil Steril 95: 2683-2686 (2011a).
142. Philibert P, Polak M, Colmenares A, Lortat-Jacob S, Audran F, et al: Predominant Sertoli cell deficiency in a 46,XY disorders of sex development patient with a new NR5A1/SF-1 mutation transmitted by his unaffected father. Fertil Steril 95: 1788.e5-9 (2011b).
143. Phillips NB, Racca J, Chen YS, Singh R, Jacso-Radek A, et al: Mammalian testis-determining factor SRY and the enigma of inherited human sex reversal: Frustrated induced fit in a bent protein-DNA complex. J Biol Chem 286: 36787-36807 (2011).
144. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Préhu MO, et al: SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18: 171-173 (1998). (Pubitemid 28082467)
145. Pingault V, Guiochon-Mantel A, Bondurand N, Faure C, Lacroix C, et al: Peripheral neuropathy with hypomyelination, chronic intestinal pseudo-obstruction and deafness: A developmental 'neural crest syndrome' related to a SOX10 mutation. Ann Neurol 48: 671-676 (2000).
146. Polanco JC, Wilhelm D, Davidson TL, Knight D, Koopman P: Sox10 gain-of-function causes XX sex reversal in mice: Implications for human 22q-linked disorders of sex development. Hum Mol Genet 19: 506-516 (2010).
147. Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A: NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 81: 576-581 (2007). (Pubitemid 47330215)
148. Qin Y, Shi Y, Zhao Y, Carson SA, Simpson JL, Chen ZJ: Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertil Steril 91 Suppl 4: 1507-1509 (2009).
149. Rajender S, Thangaraj K, Gupta NJ, Leelavathy N, Rani DS, et al: A novel human sex-determining gene linked to Xp11.21-11.23. J Clin Endocrinol Metab 91: 4028-4036 (2006). (Pubitemid 44536882)
150. Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM: NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305: 1157-1159 (2004). (Pubitemid 39100329)
151. Raymond CS, Shamu CE, Shen MM, Seifert KJ, Hirsch B, et al: Evidence for evolutionary conservation of sex-determining genes. Nature 391: 691-695 (1998). (Pubitemid 28113214)
152. Raymond CS, Murphy MW, O'Sullivan MG, Bardwell VJ, Zarkower D: Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev 14: 2587-2595 (2000).
153. Rizk B: Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome. Reprod Biomed Online 19: 14-27 (2009).
154. Schimmer BP, White PC: Minireview: Steroidogenic factor 1: Its roles in differentiation, development, and disease. Mol Endocrinol 24: 1322-1337 (2010).
155. Schlessinger D, Garcia-Ortiz JE, Forabosco A, Uda M, Crisponi L, Pelosi E: Determination and stability of gonadal sex. J Androl 31: 16-25 (2010).
156. Seeherunvong T, Perera EM, Bao Y, Benke PJ, Benigno A, et al: 46,XX sex reversal with partial duplication of chromosome arm 22q. Am J Med Genet A 127A:149-151 (2004). (Pubitemid 38649956)
157. Sekido R, Lovell-Badge R: Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 453: 930-934 (2008). (Pubitemid 351832560)
158. Sekido R, Lovell-Badge R: Sex determination and SRY: Down to a wink and a nudge? Trends Genet 25: 19-29 (2009).
159. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA: Nuclear receptor steroidogenic factor 1 regulates the mü llerian inhibiting substance gene: A link to the sex determination cascade. Cell 77: 651-661 (1994).
160. Smith CA, Roeszler KN, Ohnesorg T, Cummins DM, Farlie PG, et al: The avian Z-linked gene DMRT1 is required for male sex determination in the chicken. Nature 461: 267-271 (2009).
161. Smyk M, Berg JS, Pursley A, Curtis FK, Fernandez BA, et al: Male-to-female sex reversal associated with an approximately 250 kb deletion upstream of NR0B1 (DAX1) Hum Genet 122: 63-70 (2007). (Pubitemid 47040574)
162. Sugawara T, Kiriakidou M, McAllister JM, Kallen CB, Strauss JF 3rd: Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5 -flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry 36: 7249-7255 (1997). (Pubitemid 27258141)
163. Sultan C, Biason-Lauber A, Philibert P: Mayer-Rokitansky-Kuster-Hauser syndrome: Recent clinical and genetic findings. Gynecol Endocrinol 25: 8-11 (2009).
164. Sutton E, Hughes J, White S, Sekido R, Tan J, et al: Identification of SOX3 as an XX male sex reversal gene in mice and humans. J Clin Invest 121: 328-341 (2011).
165. Tar A, Sólyom J, Györvári B, Ion A, Telvi L, et al: Testicular development in an SRY-negative 46,XX individual harboring a distal Xp deletion. Hum Genet 96: 464-468 (1995).
166. Tevosian SG, Albrecht KH, Crispino JD, Fujiwara Y, Eicher EM, Orkin SH: Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2. Development 129: 4627-4634 (2002). (Pubitemid 35203743)
167. Thong MK, Scherer G, Kozlowski K, Haan E, Morris L: Acampomelic campomelic dysplasia with SOX9 mutation. Am J Med Genet 93: 421-425 (2000). (Pubitemid 30622190)
168. Tomaselli S, Megiorni F, De Bernardo C, Felici A, Marrocco G, et al: Syndromic true hermaphroditism due to an R-spondin1 (RSPO1) homozygous mutation. Hum Mutat 29:220-226 (2008). (Pubitemid 351240593)
169. Tomizuka K, Horikoshi K, Kitada R, Sugawara Y, Iba Y, et al: R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling. Hum Mol Genet 17: 1278-1291 (2008). (Pubitemid 351566964)
170. Touraine RL, Attié-Bitach T, Manceau E, Korsch E, Sarda P, et al: Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet 66: 1496-1503 (2000). (Pubitemid 30463068)
171. Tremblay JJ, Robert NM, Viger RS: Modulation of endogenous GATA-4 activity reveals its dual contribution to Müllerian inhibiting substance gene transcription in Sertoli cells. Mol Endocrinol 15: 1636-1650 (2001). (Pubitemid 32826415)
172. Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, et al: Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139: 1130-1142 (2009).
173. Umehara F, Tate G, Itoh K, Yamaguchi N, Douchi T, et al: A novel mutation of desert hedgehog in a patient with 46,XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 67: 1302-1305 (2000).
174. Vainio S, Heikkilä M, Kispert A, Chin N, McMahon AP: Female development in mammals is regulated by Wnt-4 signalling. Nature 397: 405-409 (1999).
175. Vetro A, Ciccone R, Giorda R, Patricelli MG, Della Mina E, et al: XX males SRY negative: A confirmed cause of infertility. J Med Genet 48: 710-712 (2011).
176. Vialard F, Ottolenghi C, Gonzales M, Choiset A, Girard S, et al: Deletion of 9p associated with gonadal dysfunction in 46,XY but not in 46,XX human fetuses. J Med Genet 39: 514-518 (2002). (Pubitemid 34787747)
177. Viger RS, Guittot SM, Anttonen M, Wilson DB, Heikinheimo M: Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol 22: 781-798 (2008). (Pubitemid 351485626)
178. Wagner T, Wirth J, Meyer J, Zabel B, Held M, et al: Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY -related gene SOX9 Cell 79: 1111-1120 (1994).
179. Warman DM, Costanzo M, Marino R, Berensztein E, Galeano J, et al: Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: within-family variability in 46,XY subjects and low ovarian reserve in fertile 46,XX subjects. Horm Res Paediatr 75: 70-77 (2011).
180. Warr N, Bogani D, Siggers P, Brixey R, Tateossian H, et al: Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP3K1. PLoS One 6:e19572 (2011).
181. Wat MJ, Shchelochkov OA, Holder AM, Breman AM, Dagli A, et al: Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A 149A:1661-1677 (2009).
182. Wieacker P, Volleth M: WNT4 and RSPO1 are not involved in a case of male-to-female sex reversal with partial duplication of 1p. Sex Dev 1: 111-113 (2007). (Pubitemid 46714638)
183. Wilhelm D, Englert C: The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1 Genes Dev 16: 1839-1851 (2002). (Pubitemid 34803899)
184. Wilson TE, Fahrner TJ, Milbrandt J: The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol 13: 5794-5804 (1993). (Pubitemid 23260680)
185. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, et al: Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 76: 833-849 (2005). (Pubitemid 40563104)
186. Wu XL, Gu MM, Huang L, Liu XS, Zhang HX, et al: Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene. Am J Hum Genet 85: 53-63 (2009).
187. Xu B, Yang WH, Gerin I, Hu CD, Hammer GD, Koenig RJ: Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol Cell Biol 29: 1719-1734 (2009).
188. Yang WH, Gutierrez NM, Wang L, Ellsworth BS, Wang CM: Synergistic activation of the Mc2r promoter by FOXL2 and NR5A1 in mice. Biol Reprod 83: 842-851 (2010).
189. Yao HH, Whoriskey W, Capel B: Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev 16: 1433-1440 (2002). (Pubitemid 34615095)
190. Zangen D, Kaufman Y, Zeligson S, Perlberg S, Fridman H, et al: XX ovarian dysgenesis is caused by a PSMC3IP/HOP2 mutation that abolishes coactivation of estrogen-driven transcription. Am J Hum Genet 89: 572-579 (2011).
191. Zhao L, Kim KW, Ikeda Y, Anderson KK, Beck L, et al: Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior. Mol Endocrinol 22: 1403-1415 (2008). (Pubitemid 351787000)
192. Zhao XX, Suzumori N, Yamaguchi M, Suzumori K: Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure. Fertil Steril 83: 1843-1844 (2005). (Pubitemid 40824825)